Kazia Therapeutics announces two abstracts on paxalisib tumor and immune reprogramming research accepted for poster presentation at the 2026 San Antonio Breast Cancer Symposium -. Company announcement.
Kazia Therapeutics announces two abstracts on paxalisib tumor and immune reprogramming research accepted for poster presentation at the 2026 San Antonio Breast Cancer Symposium -. Company announcement.
Want to see every report in real time?
Hundreds of sources worldwide, translated into your language, with alerts for what matters to you.
Sign up free Already have an account? Log in